• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT3 III; RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT3 III; RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE Back to Search Results
Model Number FT3 G3
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/21/2020
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The investigation is ongoing.
 
Event Description
The initial reporter received questionable elecsys tsh assay, elecsys ft4 iii assay, and elecsys ft3 iii results for one patient tested on a cobas 8000 e 602 module serial number (b)(4).The customer reported out the results to a physician who asked for the re-measurement of the sample.The patients sample was provided for an investigation and was tested on a cobas 8000 e 602 module.Also, the patient's sample was outsourced and tested on an abbott architect analyzer and siemens centaur analyzer.Refer to the attachment on the medwatch for all patient data.This medwatch is for ft3.Refer to the medwatch with patient identifier (b)(6) for the tsh assay and (b)(6) for the ft4 assay.
 
Manufacturer Narrative
The customer's calibration and qc data were requested but not provided.The customer provided a patient's sample for investigation.The investigation confirmed the customer's ft3 results.Upon investigation of the patient sample, an interferent against a component of the reagent was confirmed, streptavidin.This interference is covered in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT3 III
Type of Device
RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key10844275
MDR Text Key227501859
Report Number1823260-2020-02907
Device Sequence Number1
Product Code CDP
Combination Product (y/n)N
PMA/PMN Number
K963127
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 12/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFT3 G3
Device Catalogue Number06437206190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Date Manufacturer Received10/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-